Igg Laboratories manufactures the igm e igg e inmunidad antiviral en espanol reagents distributed by Genprice. The Igm E Igg E Inmunidad Antiviral En Espanol reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact igm antibody. Other Igm products are available in stock. Specificity: Igm Category: E Group: Igg E
(E) -Prop-1-en-1-ylboronic acid |
|
J&H Chemical |
1 Each |
Ask for price |
(E) -octadec-11-en-9-ynoic acid |
|
J&H Chemical |
1 Each |
Ask for price |
Igg E information
Antiviral agent 25 |
|
HY-152589 |
MedChemExpress |
Get quote |
Ask for price |
|
Description: Antiviral agent 25 (compound 6g) is a new non-peptide analog covalent inhibitor of SARS-CoV-2 3CLpro. Antiviral agent 25 has a strong inhibitory effect on SARS-CoV-2 3CLpro and SARS-CoV-2 PLpro with IC50 values of 0.118 µM, 0.448 µM, respectively. Antiviral agent 25 has antiviral effect on SARS-CoV-2 with an EC50 value of 7.249 µM[1]. |
Antiviral agent 30 |
|
HY-153758 |
MedChemExpress |
10 mg |
EUR 64.94 |
|
Description: Antiviral agent 30 (Example 118) is an antiviral agent. Antiviral agent 30 is active against HCV and RSV (IC50: > 25μM)[1]. |
Antiviral agent 34 |
|
HY-155110 |
MedChemExpress |
Get quote |
Ask for price |
|
Description: Antiviral agent 34 is a potent and orally active antiviral agent against influenza A and B subtypes with an EC50 value of 0.8 nM for H1N1 proliferation. Antiviral agent 34 derivatives inhibited influenza virus proliferation by targeting influenza virus RNA-dependent RNA polymerase. Antiviral agent 34 can be used for influenza virus research[1]. |
Antiviral agent 36 |
|
HY-155129 |
MedChemExpress |
Get quote |
Ask for price |
|
Description: Antiviral agent 36 (compound 27) is a potent dengue (DENV) and Zika (ZIKV) viruses inhibitor. Antiviral agent 36 inhibits replication of Zika and dengue virus with EC50s of 100 nM, 90 nM, 210 nM, and 120 nM for ZIKV-FLR, ZIKV-HN16, DENV-2, and DENV-3, respectively[1]. |
Antiviral agent 35 |
|
HY-155731 |
MedChemExpress |
Get quote |
Ask for price |
|
Description: Antiviral agent 35 (compound 4d) is an orally active and potent influenza virus inhibitor, acting function in the early stage of virus replication. Antiviral agent 35 inhibits ROS accumulation, autophagy and apoptosis induced by influenza virus, and also inhibits inflammatory response mediated by RIG-1 pathway in mouse model with pulmonary infection. Antiviral agent 35 shows little cytotoxicity with CC50 >800 μM in MDCK cells, and anti-H1N1 (A/Weiss/43) activity with EC50 of 2.28 μM[1]. |
Antiviral agent 43 |
|
HY-157249 |
MedChemExpress |
Get quote |
Ask for price |
|
Description: Antiviral agent 43 (compound 16) is a potent and orally active influenza A viruses entry inhibitor. Antiviral agent 43 inhibits replications of influenza A strains VH04-H5N1 and PR8-H1N1 with EC50s of 240 nM and 72 nM, respectively[1]. |
Antiviral agent 44 |
|
HY-157291 |
MedChemExpress |
Get quote |
Ask for price |
|
Description: Antiviral agent 44 (compound 7b) is an antiviral agent that has anti-HCV activity in vitro[1]. |
Antiviral agent 48 |
|
HY-157454 |
MedChemExpress |
Get quote |
Ask for price |
|
Description: Antiviral agent 48 (compound 9m) is a pan-antiviral agent. Antiviral agent 48 has anti-HEV activity and cytotoxicity (EC90=30.6 nM; CC50=13.8 nM)[1]. |
Antiviral agent 45 |
|
HY-161047 |
MedChemExpress |
Get quote |
Ask for price |
|
Description: Antiviral agent 45 (compound 9a) is an antiviral agent. Antiviral agent 45 inhibits HIV-1 andHIV-2 with IC50s of 35 and 3.1 nM, respectively[1]. |
Antiviral agent 46 |
|
HY-161070 |
MedChemExpress |
Get quote |
Ask for price |
|
Description: Antiviral agent 46 (compound 4) is a derivative of cannabidiol (CBD) with anti-SARS-CoV-2 (IC50: 1.90 μM) and ACE2 activity (IC50: 1.37 μM)[1]. |
Antiviral agent 6 |
|
HY-132911 |
MedChemExpress |
Get quote |
Ask for price |
|
Description: Antiviral agent 6 shows excellent anti-TSWV activity in vivo, and the EC50 value is 188 mg/L. |
Antiviral agent 7 |
|
HY-132916 |
MedChemExpress |
Get quote |
Ask for price |
|
Description: Antiviral agent 7 is a peptide-based coating that can kill viruses. |
Antiviral agent 14 |
|
HY-145324 |
MedChemExpress |
Get quote |
Ask for price |
|
Description: Antiviral agent 14 is an antiviral agent against the tobacco mosaic virus (TMV) and cucumber mosaic virus (CMV). The EC50 values of Antiviral agent 14 against TMV and CMV with EC50 values of 135.5 μg/mL and 178.6 μg/mL, respectively[1]. |
Antiviral agent 17 |
|
HY-146344 |
MedChemExpress |
Get quote |
Ask for price |
|
Description: Antiviral agent 17 (Compound 4) is an anti-infection agent. Antiviral agent 17 retains its antiviral effect in a human replicon assay (EC50 = 0.015 μM). Antiviral agent 17 results in good antiviral activity against murine norovirus. Antiviral agent 17 has the potential for the research of infectious and malignant diseases[1]. |
Antiviral agent 18 |
|
HY-146345 |
MedChemExpress |
Get quote |
Ask for price |
|
Description: Antiviral agent 18 (Compound 5) is an anti-infection agent. Antiviral agent 18 results in good antiviral activity against murine norovirus. Antiviral agent 18 has the potential for the research of infectious and malignant diseases[1]. |
Antiviral agent 19 |
|
HY-146417 |
MedChemExpress |
Get quote |
Ask for price |
|
Description: Antiviral agent 19 (Compound 3) is a selective inhibitor against Zika virus infection with an EC50 of 1.3 µM. Antiviral agent 19 has low cytotoxicity[1]. |
Antiviral agent 20 |
|
HY-146418 |
MedChemExpress |
Get quote |
Ask for price |
|
Description: Antiviral agent 20 (Compound 17b) is a selective inhibitor against Zika virus infection with an EC50 of 4.5 µM. Antiviral agent 20 has low cytotoxicity[1]. |